Active Ingredient: EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Proprietary Name: ATRIPLA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 600MG;200MG;300MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021937
Product Number: 001
Approval Date: Jul 12, 2006
Applicant Holder Full Name: GILEAD SCIENCES LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information
